Tenet Healthcare (NYSE:THC) Director Cecil Haney Sells 1,300 Shares of Stock

Tenet Healthcare Corporation (NYSE:THC) Director Cecil Haney sold 1,300 shares of the company’s stock in a transaction on Monday, August 24th. The stock was sold at an average price of $278.03, for a total transaction of $361,439.00. Following the transaction, the director owned 12,553 shares of the company’s stock, valued at approximately $3,490,110.59. This represents a 9.38% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.

Tenet Healthcare Price Performance

NYSE THC traded up $2.18 on Wednesday, reaching $274.06. The company had a trading volume of 513,308 shares, compared to its average volume of 844,938. The firm’s 50 day moving average price is $226.21 and its 200 day moving average price is $208.66. Tenet Healthcare Corporation has a 12 month low of $157.58 and a 12 month high of $283.05. The stock has a market capitalization of $22.07 billion, a PE ratio of 10.57, a price-to-earnings-growth ratio of 1.04 and a beta of 1.23. The company has a quick ratio of 1.35, a current ratio of 1.41 and a debt-to-equity ratio of 2.00.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings data on Thursday, July 23rd. The company reported $6.12 earnings per share for the quarter, beating analysts’ consensus estimates of $4.26 by $1.86. Tenet Healthcare had a return on equity of 26.76% and a net margin of 10.27%.The firm had revenue of $6.04 billion during the quarter, compared to analyst estimates of $5.43 billion. During the same quarter last year, the business posted $4.02 earnings per share. The business’s quarterly revenue was up 6.8% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. As a group, equities analysts predict that Tenet Healthcare Corporation will post 20.98 earnings per share for the current year.

Analyst Ratings Changes

A number of equities analysts recently commented on THC shares. Mizuho set a $290.00 price target on shares of Tenet Healthcare in a research note on Monday, August 10th. Robert W. Baird boosted their target price on Tenet Healthcare from $210.00 to $280.00 and gave the company a “neutral” rating in a research report on Tuesday, July 28th. Barclays increased their price target on Tenet Healthcare from $240.00 to $271.00 and gave the stock an “overweight” rating in a report on Friday, July 24th. UBS Group raised their price target on Tenet Healthcare from $288.00 to $308.00 and gave the stock a “buy” rating in a research note on Monday, July 27th. Finally, Raymond James Financial reaffirmed an “outperform” rating and issued a $285.00 price objective on shares of Tenet Healthcare in a research report on Friday, August 14th. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and one has given a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Buy” and an average price target of $273.00.

Institutional Investors Weigh In On Tenet Healthcare

Several large investors have recently modified their holdings of THC. California State Teachers Retirement System boosted its stake in shares of Tenet Healthcare by 18,362.2% during the second quarter. California State Teachers Retirement System now owns 18,885,726 shares of the company’s stock valued at $3,533,142,000 after purchasing an additional 18,783,432 shares in the last quarter. Norges Bank purchased a new position in shares of Tenet Healthcare in the 4th quarter valued at $248,494,000. Wellington Management Group LLP raised its position in shares of Tenet Healthcare by 1,114.2% in the 4th quarter. Wellington Management Group LLP now owns 1,135,801 shares of the company’s stock worth $225,706,000 after acquiring an additional 1,042,260 shares in the last quarter. Manning & Napier Advisors LLC purchased a new stake in shares of Tenet Healthcare during the 2nd quarter worth $168,761,000. Finally, Boston Partners raised its holdings in Tenet Healthcare by 38.8% in the third quarter. Boston Partners now owns 3,147,555 shares of the company’s stock worth $638,958,000 after purchasing an additional 880,413 shares in the last quarter. Institutional investors own 95.44% of the company’s stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.